Botox 200 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FQSU5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,844
Award facts
- Contract value 100% obligated
- $15,843.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $15,843.84 to DMS Pharmaceutical Group Inc. for BOTOX 200 Unit Vials on December 1, 2025, with an ultimate completion date of December 22, 2025. This firm fixed-price delivery order was awarded without a set-aside designation to the woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. The order represents a discrete purchase under DMS Pharmaceutical Group's broader pharmaceutical supply relationship with the federal government.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR. That master contract, awarded November 13, 2025, carries a $499,999,999 ceiling and extends through December 31, 2036, positioning the company as a regional prime vendor within the $30.3 billion PPV-G GEN V acquisition strategy. As an established supplier within the DLA's Medical Supply Chain division, DMS Pharmaceutical Group supplies a comprehensive range of pharmaceutical products and medical consumables to support Department of Defense healthcare operations globally, demonstrating consistent performance across multiple therapeutic categories and product lines.
Quick answers
Who was awarded contract SPE2DR26FQSU5?
SPE2DR26FQSU5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 1, 2025.
How much is contract SPE2DR26FQSU5 worth?
The government has obligated $15,844 on SPE2DR26FQSU5.
Is contract SPE2DR26FQSU5 an order under another contract?
Yes. SPE2DR26FQSU5 is a delivery order under SPE2DR25D9214, an indefinite delivery contract.
Was contract SPE2DR26FQSU5 competed?
The extent of competition for SPE2DR26FQSU5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award